Intangible Assets

9 Months Ended

Apr. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 3.       Intangible Assets

Intangible assets at April 30, 2022, consisted of costs related to a patent for our PRV-002 drug device combination.

Amortization expense was as follows: 

	Three Months Ended April 30,				Nine Months Ended April 30,
		2022		2021		2022		2021
Amortization expense	$	754	$	–	$	1,206	$	–

Future amortization of intangible assets is as follows:

Remainder of fiscal 2022	$	754
Fiscal 2023		3,015
Fiscal 2024		3,015
Fiscal 2025		3,015
Fiscal 2026		3,015
Thereafter		31,200
	$	44,014